Bowel cancer (also known as colorectal cancer) affects 15,500 men and women in Australia each year.
The good news is the National Bowel Cancer Screening Program is helping reduce the burden of bowel cancer.
Sadly though, half of all bowel cancer diagnoses will spread to the liver, where it is often unresponsive to current treatments. That is why more research is needed to tackle this deadly disease.
Bowel Cancer Support
Fast-tracking the development of a novel probiotic pill to diagnose bowel cancer.
Introducing a noval faecal test to determine which individuals should be prioritised for urgent colonoscopy.
Trialling a new approach to treating aggressive bowel cancer called personalised Total Neoadjuvant Therapy (pTNT) to improve outcomes for high risk patients at the Royal Adelaide Hospital.
Investigating a protein called ROCK which has been found to promote the spread of bowel cancer, and then finding ways to inhibit the cancer’s growth.
Investigating the increased prevalence of bowel cancer in adults under 50 and its links to Type 2 diabetes.
Building a biobank of liver metastatic bowel cancer tissue to analyse and identify biomarkers to help predict whether bowel cancer is likely to spread.
Increasing awareness in the community of the importance of taking a bowel cancer screening test by funding the Jodi Lee Foundation’s awareness campaign and workplace prevention program.
Developing a Computer Aided Diagnostic (CAD) system to provide a detailed analysis in real time of polyps found during a colonoscopy, to avoid the time delay of sending specimens to the lab.